1
Nov 16 (Reuters) – Allarity Therapeutics Inc: * ALLARITY THERAPEUTICS EXPANDS PHASE 2 STENOPARIB TRIAL TO THREE OVARIAN CANCER PATIENT COHORTS Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)